Updated Saturday, April 21, 2018
 Journal Tools
RSS Feed
Sample Copy
Submit a Manuscript
Contact Us
Subscription
Advertising
Thanking Peer Reviewers
 Language Polishing
Journal of Integrative Medicine: Volume 12, 2014   Issue 1,  Pages: 20-34

DOI: 10.1016/S2095-4964(14)60003-0
Research Article
Pristimerin enhances recombinant adeno-associated virus vector-mediated transgene expression in human cell lines in vitro and murine hepatocytes in vivo
1. Li-na Wang (Changhai Hospital of Traditional Chinese Medicine, Second Military Medical University, Shanghai 200433, China )
2. Yuan Wang (Changhai Hospital of Traditional Chinese Medicine, Second Military Medical University, Shanghai 200433, China )
3. Yuan Lu (Department of Orthopaedics and Rehabilitation, University of Florida College of Medicine, Gainesville, Florida 32611, USA )
4. Zi-fei Yin (Changhai Hospital of Traditional Chinese Medicine, Second Military Medical University, Shanghai 200433, China )
5. Yuan-hui Zhang (Changhai Hospital of Traditional Chinese Medicine, Second Military Medical University, Shanghai 200433, China )
6. George V. Aslanidi (Division of Cellular and Molecular Therapy, Department of Pediatrics, University of Florida College of Medicine, Gainesville, Florida 32611, USA )
7. Arun Srivastava (Division of Cellular and Molecular Therapy, Department of Pediatrics, University of Florida College of Medicine, Gainesville, Florida 32611, USA )
8. Chang-quan Ling (Changhai Hospital of Traditional Chinese Medicine, Second Military Medical University, Shanghai 200433, China E-mail: lingchangquan@gmail.com)
9. Chen Ling (Division of Cellular and Molecular Therapy, Department of Pediatrics, University of Florida College of Medicine, Gainesville, Florida 32611, USA E-mail: lingchen@peds.ufl.edu)

OBJECTIVE: In the present study, we systemically evaluated the ability of two bioactive compounds from traditional Chinese medicine, celastrol and pristimerin, to enhance recombinant adeno-associated virus (rAAV) serotype vector-mediated transgene expression both in human cell lines in vitro, and in murine hepatocytes in vivo.

METHODS: Human cell lines were infected with rAAV vectors with either mock treatment or treatment with celastrol or pristimerin. The transgene expression, percentage of nuclear translocated viral genomes and the ubiquitination of intracellular proteins were investigated post-treatment. In addition, nonobese diabetic/severe combined immunodeficient gamma (NSG) mice were tail vain-injected with rAAV vectors and co-administered with either dimethyl sulfoxide, celastrol, pristimerin or a positive control, bortezomib. The transgene expression in liver was detected and compared over time.

RESULTS: We observed that treatment with pristimerin, at as low as 1 μmol/L concentration, significantly enhanced rAAV2 vector-mediated transgene expression in vitro, and intraperitoneal co-administration with pristimerin at 4 mg/(kg·d) for 3 d dramatically facilitated viral transduction in murine hepatocytes in vivo. The transduction efficiency of the tyrosine-mutant rAAV2 vectors as well as that of rAAV8 vectors carrying oversized transgene cassette was also augmented significantly by pristimerin. The underlying molecular mechanisms by which pristimerin mediated the observed increase in the transduction efficiency of rAAV vectors include both inhibition of proteasomal degradation of the intracellular proteins and enhanced nuclear translocation of the vector genomes.

CONCLUSION: These studies suggest the potential beneficial use of pristimerin and pristimerin-containing herb extract in future liver-targeted gene therapy with rAAV vectors.

Welcome to JIM! You are the number 38278 reader of this article!
Download Article:
[Full Text]      [PDF]      [Previous]      [Next]      [This Issue]
Please cite this article as:
Wang LN, Wang Y, Lu Y, Yin ZF, Zhang YH, Aslanidi GV, Srivastava A, Ling CQ, Ling C. Pristimerin enhances recombinant adeno-associated virus vector-mediated transgene expression in human cell lines in vitro and murine hepatocytes in vivo. J Integr Med. 2014; 12(1): 20-34.
References:
1Atchison RW, Casto BC, Hammon WM. Adenovirus-associated defective virus particles[J].Science, 1965, 149(3685): 754-756.  
2Lebkowski JS, McNally MM, Okarma TB, Lerch LB. Adeno-associated virus: a vector system for efficient introduction and integration of DNA into a variety of mammalian cell types[J].Mol Cell Biol, 1988, 8(10): 3988-3996.  
3Mingozzi F, High KA. Therapeutic in vivo gene transfer for genetic disease using AAV: progress and challenges[J].Nat Rev Genet, 2011, 12(5): 341-355.  
4Daya S, Berns KI. Gene therapy using adeno-associated virus vectors[J].Clin Microbiol Rev, 2008, 21(4): 583-593.  
5Bainbridge JW, Smith AJ, Barker SS, Robbie S, Henderson R, Balaggan K, Viswanathan A, Holder GE, Stockman A, Tyler N, Petersen-Jones S, Bhattacharya SS, Thrasher AJ, Fitzke FW, Carter BJ, Rubin GS, Moore AT, Ali RR. Effect of gene therapy on visual function in Leber’s congenital amaurosis[J].N Engl J Med, 2008, 358(21): 2231-2239.  
6Maguire AM, Simonelli F, Pierce EA, Pugh EN Jr, Mingozzi F, Bennicelli J, Banfi S, Marshall KA, Testa F, Surace EM, Rossi S, Lyubarsky A, Arruda VR, Konkle B, Stone E, Sun J, Jacobs J, Dell’Osso L, Hertle R, Ma JX, Redmond TM, Zhu X, Hauck B, Zelenaia O, Shindler KS, Maguire MG, Wright JF, Volpe NJ, McDonnell JW, Auricchio A, High KA, Bennett J. Safety and efficacy of gene transfer for Leber’s congenital amaurosis[J].N Engl J Med, 2008, 358(21): 2240-2248.  
7Cideciyan AV, Aleman TS, Boye SL, Schwartz SB, Kaushal S, Roman AJ, Pang JJ, Sumaroka A, Windsor EA, Wilson JM, Flotte TR, Fishman GA, Heon E, Stone EM, Byrne BJ, Jacobson SG, Hauswirth WW. Human gene therapy for RPE65 isomerase deficiency activates the retinoid cycle of vision but with slow rod kinetics[J].Proc Natl Acad Sci U S A, 2008, 105(39): 15112-15117.  
8Nathwani AC, Tuddenham EG, Rangarajan S, Rosales C, McIntosh J, Linch DC, Chowdary P, Riddell A, Pie AJ, Harrington C, O’Beirne J, Smith K, Pasi J, Glader B, Rustagi P, Ng CY, Kay MA, Zhou J, Spence Y, Morton CL, Allay J, Coleman J, Sleep S, Cunningham JM, Srivastava D, Basner-Tschakarjan E, Mingozzi F, High KA, Gray JT, Reiss UM, Nienhuis AW, Davidoff AM. Adenovirus-associated virus vector-mediated gene transfer in hemophilia B[J].N Engl J Med, 2011, 365(25): 2357-2365.  
9Hwu WL, Muramatsu S, Tseng SH, Tzen KY, Lee NC, Chien YH, Snyder RO, Byrne BJ, Tai CH, Wu RM. Gene therapy for aromatic L-amino acid decarboxylase deficiency[J].Sci Transl Med, 2012, 4(134): 134ra61.  
10Gao GP, Alvira MR, Wang L, Calcedo R, Johnston J, Wilson JM. Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy[J].Proc Natl Acad Sci U S A, 2002, 99(18): 11854-11859.  
11McCarty DM, Fu H, Monahan PE, Toulson CE, Naik P, Samulski RJ. Adeno-associated virus terminal repeat (TR) mutant generates self-complementary vectors to overcome the rate-limiting step to transduction in vivo[J].Gene Ther, 2003, 10(26): 2112-2118.  
12Wang Z, Ma HI, Li J, Sun L, Zhang J, Xiao X. Rapid and highly efficient transduction by double-stranded adeno-associated virus vectors in vitro and in vivo[J].Gene Ther, 2003, 10(26): 2105-2111.  
13Nathwani AC, Gray JT, Ng CY, Zhou J, Spence Y, Waddington SN, Tuddenham EG, Kemball-Cook G, McIntosh J, Boon-Spijker M, Mertens K, Davidoff AM. Self-complementary adeno-associated virus vectors containing a novel liver-specific human factor IX expression cassette enable highly efficient transduction of murine and nonhuman primate liver[J].Blood, 2006, 107(7): 2653-2661.  
14Wang X, Zhang A, Sun H, Wang P. Systems biology technologies enable personalized traditional Chinese medicine: a systematic review[J].Am J Chin Med, 2012, 40(6): 1109-1122.  
15Zheng WL, Ma WL. Gene therapy through digestive tract — the elucidation of the mechanism of traditional Chinese medicine[J].Ke Ji Dao Bao, 1994, (12): 8-11.  
16Li B, Gu W, Zhang C, Huang XQ, Han KQ, Ling CQ. Growth arrest and apoptosis of the human hepatocellular carcinoma cell line BEL-7402 induced by melittin[J].Onkologie, 2006, 29(8-9): 367-371.  
17Zhang FL, Jia SQ, Zheng SP, Ding W. Celastrol enhances AAV1-mediated gene expression in mice adipose tissues[J].Gene Ther, 2011, 18(2): 128-134.  
18Mitchell AM, Li C, Samulski RJ. Arsenic trioxide stabilizes accumulations of adeno-associated virus virions at the perinuclear region, increasing transduction in vitro and in vivo[J].J Virol, 2013, 87(8): 4571-4583.  
19Duan D, Yue Y, Yan Z, Yang J, Engelhardt JF. Endosomal processing limits gene transfer to polarized airway epithelia by adeno-associated virus[J].J Clin Invest, 2000, 105(11): 1573-1587.  
20Douar AM, Poulard K, Stockholm D, Danos O. Intracellular trafficking of adeno-associated virus vectors: routing to the late endosomal compartment and proteasome degradation[J].J Virol, 2001, 75(4): 1824-1833.  
21Ding W, Zhang LN, Yeaman C, Engelhardt JF. rAAV2 traffics through both the late and the recycling endosomes in a dose-dependent fashion[J].Mol Ther, 2006, 13(4): 671-682.  
22Buffa Filho W, Corsino J, Bolzani da SV, Furlan M, Pereira AM, Fran?a SC. Quantitative determination for cytotoxic Friedo-nor-oleanane derivatives from five morphological types of Maytenus ilicifolia (Celastraceae) by reverse-phase high-performance liquid chromatography[J].Phytochem Anal, 2002, 13(2): 75-78.  
23Brinker AM, Ma J, Lipsky PE, Raskin I. Medicinal chemistry and pharmacology of genus Tripterygium (Celastraceae)[J].Phytochemistry, 2007, 68(6): 732-766.  
24Yang H, Liu J, Dou QP. Targeting tumor proteasome with traditional Chinese medicine[J].Curr Drug Discov Technol, 2010, 7(1): 46-53.  
25Yang H, Chen D, Cui QC, Yuan X, Dou QP. Celastrol, a triterpene extracted from the Chinese “Thunder of God Vine,” is a potent proteasome inhibitor and suppresses human prostate cancer growth in nude mice[J].Cancer Res, 2006, 66(9): 4758-4765.  
26Yang H, Landis-Piwowar KR, Lu D, Yuan P, Li L, Reddy GP, Yuan X, Dou QP. Pristimerin induces apoptosis by targeting the proteasome in prostate cancer cells[J].J Cell Biochem, 2008, 103(1): 234-244.  
27Wu J, Zhao W, Zhong L, Han Z, Li B, Ma W, Weigel-Kelley KA, Warrington KH, Srivastava A. Self-complementary recombinant adeno-associated viral vectors: packaging capacity and the role of rep proteins in vector purity[J].Hum Gene Ther, 2007, 18(2): 171-182.  
28Wang Y, Ling C, Song L, Wang L, Aslanidi GV, Tan M, Ling C, Srivastava A. Limitations of encapsidation of recombinant self-complementary adeno-associated viral genomes in different serotype capsids and their quantitation[J].Hum Gene Ther Methods, 2012, 23(4): 225-233.  
29Ling C, Lu Y, Kalsi JK, Jayandharan GR, Li B, Ma W, Cheng B, Gee SW, McGoogan KE, Govindasamy L, Zhong L, Agbandje-McKenna M, Srivastava A. Human hepatocyte growth factor receptor is a cellular coreceptor for adeno-associated virus serotype 3[J].Hum Gene Ther, 2010, 21(12): 1741-1747.  
30Ling C, Lu Y, Cheng B, McGoogan KE, Gee SW, Ma W, Li B, Aslanidi GV, Srivastava A. High-efficiency transduction of liver cancer cells by recombinant adeno-associated virus serotype 3 vectors[J].J Vis Exp, 2011, (49): pii: 2538.  
31Song L, Kauss MA, Kopin E, Chandra M, Ul-Hasan T, Miller E, Jayandharan GR, Rivers AE, Aslanidi GV, Ling C, Li B, Ma W, Li X, Andino LM, Zhong L, Tarantal AF, Yoder MC, Wong KK Jr, Tan M, Chatterjee S, Srivastava A. Optimizing the transduction efficiency of capsid-modified AAV6 serotype vectors in primary human hematopoietic stem cells in vitro and in a xenograft mouse model in vivo[J].Cytotherapy, 2013, 15(8): 986-998.  
32Ding W, Yan Z, Zak R, Saavedra M, Rodman DM, Engelhardt JF. Second-strand genome conversion of adeno-associated virus type 2 (AAV-2) and AAV-5 is not rate limiting following apical infection of polarized human airway epithelia[J].J Virol, 2003, 77(13): 7361-7366.  
33Glickman MH, Ciechanover A. The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction[J].Physiol Rev, 2002, 82(2): 373-428.  
34Shultz LD, Lyons BL, Burzenski LM, Gott B, Chen X, Chaleff S, Kotb M, Gillies SD, King M, Mangada J, Greiner DL, Handgretinger R. Human lymphoid and myeloid cell development in NOD/LtSz-scid IL2R gamma null mice engrafted with mobilized human hemopoietic stem cells[J].J Immunol, 2005, 174(10): 6477-6489.  
35Markusic DM, Herzog RW, Aslanidi GV, Hoffman BE, Li B, Li M, Jayandharan GR, Ling C, Zolotukhin I, Ma W, Zolotukhin S, Srivastava A, Zhong L. High-efficiency transduction and correction of murine hemophilia B using AAV2 vectors devoid of multiple surface-exposed tyrosines[J].Mol Ther, 2010, 18(12): 2048-2056.  
36Zincarelli C, Soltys S, Rengo G, Rabinowitz JE. Analysis of AAV serotypes 1-9 mediated gene expression and tropism in mice after systemic injection[J].Mol Ther, 2008, 16(6): 1073-1080.  
37Monahan PE, Lothrop CD, Sun J, Hirsch ML, Kafri T, Kantor B, Sarkar R, Tillson DM, Elia JR, Samulski RJ. Proteasome inhibitors enhance gene delivery by AAV virus vectors expressing large genomes in hemophilia mouse and dog models: a strategy for broad clinical application[J].Mol Ther, 2010, 18(11): 1907-1916.  
38Pajusola K, Gruchala M, Joch H, Lüscher TF, Yl?-Herttuala S, Büeler H. Cell-type-specific characteristics modulate the transduction efficiency of adeno-associated virus type 2 and restrain infection of endothelial cells[J].J Virol, 2002, 76(22): 11530-11540.  
39Yan Z, Zak R, Zhang Y, Ding W, Godwin S, Munson K, Peluso R, Engelhardt JF. Distinct classes of proteasome-modulating agents cooperatively augment recombinant adeno-associated virus type 2 and type 5-mediated transduction from the apical surfaces of human airway epithelia[J].J Virol, 2004, 78(6): 2863-2874.  
40Luo DQ, Wang H, Tian X, Shao HJ, Liu JK. Antifungal properties of pristimerin and celastrol isolated from Celastrus hypoleucus[J].Pest Manag Sci, 2005, 61(1): 85-90.  
41Tiedemann RE, Schmidt J, Keats JJ, Shi CX, Zhu YX, Palmer SE, Mao X, Schimmer AD, Stewart AK. Identification of a potent natural triterpenoid inhibitor of proteosome chymotrypsin-like activity and NF-κB with antimyeloma activity in vitro and in vivo[J].Blood, 2009, 113(17): 4027-4037.  
42Zhong L, Li B, Mah CS, Govindasamy L, Agbandje-McKenna M, Cooper M, Herzog RW, Zolotukhin I, Warrington KH Jr, Weigel-Van Aken KA, Hobbs JA, Zolotukhin S, Muzyczka N, Srivastava A. Next generation of adeno-associated virus 2 vectors: point mutations in tyrosines lead to high-efficiency transduction at lower doses[J].Proc Natl Acad Sci U S A, 2008, 105(22): 7827-7832.  
43Aslanidi GV, Rivers AE, Ortiz L, Govindasamy L, Ling C, Jayandharan GR, Zolotukhin S, Agbandje-McKenna M, Srivastava A. High-efficiency transduction of human monocyte-derived dendritic cells by capsid-modified recombinant AAV2 vectors[J].Vaccine, 2012, 30(26): 3908-3917.  
44Dong B, Nakai H, Xiao W. Characterization of genome integrity for oversized recombinant AAV vector[J].Mol Ther, 2010, 18(1): 87-92.  
45Lai Y, Yue Y, Duan D. Evidence for the failure of adeno-associated virus serotype 5 to package a viral genome > or = 8.2 kb[J].Mol Ther, 2010, 18(1): 75-79.  
46Wu Z, Yang H, Colosi P. Effect of genome size on AAV vector packaging[J].Mol Ther, 2010, 18(1): 80-86.  
47Zhang T, Hu J, Ding W, Wang X. Doxorubicin augments rAAV-2 transduction in rat neuronal cells[J].Neurochem Int, 2009, 55(7): 521-528.  
48Denby L, Nicklin SA, Baker AH. Adeno-associated virus (AAV)-7 and -8 poorly transduce vascular endothelial cells and are sensitive to proteasomal degradation[J].Gene Ther, 2005, 12(20): 1534-1538.  
49Besse B, Planchard D, Veillard AS, Taillade L, Khayat D, Ducourtieux M, Pignon JP, Lumbroso J, Lafontaine C, Mathiot C, Soria JC. Phase 2 study of frontline bortezomib in patients with advanced non-small cell lung cancer[J].Lung Cancer, 2012, 76(1): 78-83.  
50Kim GP, Mahoney MR, Szydlo D, Mok TS, Marshke R, Holen K, Picus J, Boyer M, Pitot HC, Rubin J, Philip PA, Nowak A, Wright JJ, Erlichman C. An international, multicenter phase II trial of bortezomib in patients with hepatocellular carcinoma[J].Invest New Drugs, 2012, 30(1): 387-394.  
51Wu S, Chen JJ, Kudelka A, Lu J, Zhu X. Incidence and risk of hypertension with sorafenib in patients with cancer: a systematic review and meta-analysis[J].Lancet Oncol, 2008, 9(2): 117-123.  
52Wang S, Liu K, Wang X, He Q, Chen X. Toxic effects of celastrol on embryonic development of zebrafish (Danio rerio)[J].Drug Chem Toxicol, 2011, 34(1): 61-65.  
53Kim HJ, Park GM, Kim JK. Anti-inflammatory effect of pristimerin on lipopolysaccharide-induced inflammatory responses in murine macrophages[J].Arch Pharm Res, 2013, 36(4): 495-500.  
54Sassa H, Kogure K, Takaishi Y, Terada H. Structural basis of potent antiperoxidation activity of the triterpene celastrol in mitochondria: effect of negative membrane surface charge on lipid peroxidation[J].Free Radic Biol Med, 1994, 17(3): 201-207.  
55Figueiredo JN, R?z B, Séquin U. Novel quinone methides from Salacia kraussii with in vitro antimalarial activity[J].J Nat Prod, 1998, 61(6): 718-723.  
56Avilla J, Teixido A, Velazquez C, Alvarenga N, Ferro E, Canela R. Insecticidal activity of Maytenus species (Celastraceae) nortriterpene quinone methides against codling moth, Cydia pomonella (L.) (Lepidoptera: tortricidae)[J].J Agric Food Chem, 2000, 48(1): 88-92.  
57Lu Z, Jin Y, Chen C, Li J, Cao Q, Pan J. Pristimerin induces apoptosis in imatinib-resistant chronic myelogenous leukemia cells harboring T315I mutation by blocking NF-κB signaling and depleting Bcr-Abl[J].Mol Cancer, 2010, 9: 112.  
58Jayandharan GR, Aslanidi G, Martino AT, Jahn SC, Perrin GQ, Herzog RW, Srivastava A. Activation of the NF-κB pathway by adeno-associated virus (AAV) vectors and its implications in immune response and gene therapy[J].Proc Natl Acad Sci U S A, 2011, 108(9): 3743-3748.  
59Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics[J].CA Cancer J Clin, 2011, 61(2): 69-90.  
60El-Serag HB. Hepatocellular carcinoma[J].N Engl J Med, 2011, 365(12): 1118-1127.  
61Chen WQ, Zheng RS, Zhang SW. Liver cancer incidence and mortality in China, 2009[J].Chin J Cancer, 2013, 32(4): 162-169.  
62Llovet JM, Ricci S, Mazzaferro V, Hilgard P, Gane E, Blanc JF, de Oliveira AC, Santoro A, Raoul JL, Forner A, Schwartz M, Porta C, Zeuzem S, Bolondi L, Greten TF, Galle PR, Seitz JF, Borbath I, H?ussinger D, Giannaris T, Shan M, Moscovici M, Voliotis D, Bruix J; SHARP Investigators Study Group. Sorafenib in advanced hepatocellular carcinoma[J].N Engl J Med, 2008, 359(4): 378-390.  
63Cheng B, Ling C, Dai Y, Lu Y, Glushakova LG, Gee SW, McGoogan KE, Aslanidi GV, Park M, Stacpoole PW, Siemann D, Liu C, Srivastava A, Ling C. Development of optimized AAV3 serotype vectors: mechanism of high-efficiency transduction of human liver cancer cells[J].Gene Ther, 2012, 19(4): 375-384.  
64Kota J, Chivukula RR, O’Donnell KA, Wentzel EA, Montgomery CL, Hwang HW, Chang TC, Vivekanandan P, Torbenson M, Clark KR, Mendell JR, Mendell JT. Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model[J].Cell, 2009, 137(6): 1005-1017.  
65Wu MC. Traditional Chinese medicine in prevention and treatment of liver cancer: function, status and existed problems[J]. J Chin Integr Med, 2003, 1(3): 163-164.  
66Li M, Qiao C, Qin L, Zhang J, Ling C. Application of traditional Chinese medicine injection in treatment of primary liver cancer: a review[J].J Tradit Chin Med, 2012, 32(3): 299-307.  
67Zhai XF, Chen Z, Li B, Shen F, Fan J, Zhou WP, Yang YK, Xu J, Qin X, Li LQ, Ling CQ. Traditional herbal medicine in preventing recurrence after resection of small hepatocellular carcinoma: a multicenter randomized controlled trial[J]. J Integr Med, 2013, 11(2): 90-100.  
68Yu H, Zhu GY, Xu RZ, Niu HZ, Lu Q, Li GZ, Wang ZY, Zhang DS, Gu N, Teng GJ. Arterial embolization hyperthermia using As2O3 nanoparticles in VX2 carcinoma-induced liver tumors[J].PLoS One, 2011, 6(3): e17926.  
69Qu FL, Hao XZ, Qin SK, Liu JW, Sui GJ, Chen Q, Qu T, Zhang HP, Sun Y. Multicenter phase II clinical trial of arsenic trioxide injection in the treatment of primary hepatocarcinoma[J].Zhonghua Zhong Liu Za Zhi, 2011, 33(9): 697-701.  
70Yi H, Du BY, Tan YH, Liu AJ, Luo H, Luo XX, Su JF, Wang HF. Joint therapeutic effect of hepatocarcinoma suicide gene therapy combined with Liuwei Dihuangwan on expression of connexin in vitro[J].Zhongguo Shi Yan Fang Ji Xue Za Zhi, 2011, 17(12): 114-118.  
71Wang CJ, Li JJ, Chen ZB, Liu YZ, Xu XM, Deng L, Pan JQ. Chinese herbs of invigorating the spleen and removing blood stasis (JPHY) improve killing effects of CD/TK double suicide genes on human hepatocellular carcinoma[J].Xian Dai Sheng Wu Yi Xue Jin Zhan, 2008, 8(9): 1605-1607.  
 Home | Current Issue | Past Issues | SearchRSS
Copyright © 2013-2018 by JIM Editorial Office. All rights reserved. ISSN 2095-4964; CN 31-2083/R. 沪ICP备110264号